U.S. to Buy Lilly Antibody; Germany’s New Curbs: Virus Update

The U.S. agreed to pay Eli Lilly & Co. $375 million for 300,000 vials of its experimental Covid-19 antibody, underscoring governments’ appetite for any pandemic solution as the virus stages a comeback in the northern hemisphere.